Neuroinvasive Disease and West Nile Virus Infection, North Dakota, USA, 1999-2008

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2012 Apr 4

PMID 22469465

Citations 56

Authors

Paul J Carson

Stephanie M Borchardt

Brian Custer

Harry E Prince

Joan Dunn-Williams

Valerie Winkelman

Leslie Tobler

Brad J Biggerstaff

Robert Lanciotti

Lyle R Petersen

Michael P Busch

Affiliations

Soon will be listed here.

Abstract

To determine risk for West Nile virus (WNV) neuroinvasive disease in North Dakota, we tested plasma samples from blood donors for WNV IgG and compared infection rates with reported WNV neuroinvasive disease incidence. We estimate that 1 in 244 WNV infections leads to neuroinvasive disease; risk is substantially increased among men and older persons.

Citing Articles

Whole-Blood PCR Preferred for Timely Diagnosis of Neuroinvasive West Nile Virus Infections: Lessons From the 2021 Arizona Outbreak.

Kasule S, Fernholz E, Grant L, Kole A, Grys T, Kaleta E Open Forum Infect Dis. 2024; 11(5):ofae188.

PMID: 38680608 PMC: 11055396. DOI: 10.1093/ofid/ofae188.

Estimation of time-dependent arbovirus infection risk in blood and tissue donations.

Biggerstaff B Stat Commun Infect Dis. 2024; 12(1).

PMID: 38618187 PMC: 11010585. DOI: 10.1515/scid-2020-0001.

Inflammatory Response Associated with West Nile Neuroinvasive Disease: A Systematic Review.

Pavesi A, Tiecco G, Rossi L, Sforza A, Ciccarone A, Compostella F Viruses. 2024; 16(3).

PMID: 38543749 PMC: 10976239. DOI: 10.3390/v16030383.

Multi-Model Prediction of West Nile Virus Neuroinvasive Disease With Machine Learning for Identification of Important Regional Climatic Drivers.

Holcomb K, Staples J, Nett R, Beard C, Petersen L, Benjamin S Geohealth. 2023; 7(11):e2023GH000906.

PMID: 38023388 PMC: 10654557. DOI: 10.1029/2023GH000906.

Demographic characteristics associated with West Nile virus neuroinvasive disease - A retrospective study on the wider European area 2006-2021.

Riccetti N, Ferraccioli F, Fasano A, Stilianakis N PLoS One. 2023; 18(9):e0292187.

PMID: 37768957 PMC: 10538693. DOI: 10.1371/journal.pone.0292187.

References

Lindsey N, Kuhn S, Campbell G, Hayes E . West Nile virus neuroinvasive disease incidence in the United States, 2002-2006. Vector Borne Zoonotic Dis. 2008; 8(1):35-9. DOI: 10.1089/vbz.2007.0137. View

Michaels S, Balsamo G, Kukreja M, Anderson C, Straif-Bourgeois S, Talati G . Surveillance for West Nile virus cases in Louisiana 2001-2004. J La State Med Soc. 2005; 157(5):269-72. View

Petersen L, Hayes E . Westward ho?--The spread of West Nile virus. N Engl J Med. 2004; 351(22):2257-9. DOI: 10.1056/NEJMp048261. View

Schellenberg T, Anderson M, Drebot M, Vooght M, Findlater A, Curry P . Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health. 2006; 97(5):369-73. PMC: 6975729. View

Meyer T, Bull L, Cain Holmes K, Pascua R, da Rosa A, Gutierrez C . West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis. 2008; 13(10):1500-3. PMC: 2851536. DOI: 10.3201/eid1310.070442. View

Schweitzer B, Kramer W, Sambol A, Meza J, Hinrichs S, Iwen P . Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006; 13(3):314-8. PMC: 1391969. DOI: 10.1128/CVI.13.3.314-318.2006. View

Murphy T, Grandpre J, Novick S, Seys S, Harris R, Musgrave K . West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis. 2005; 5(3):246-51. DOI: 10.1089/vbz.2005.5.246. View

Mandalakas A, Kippes C, Sedransk J, Kile J, Garg A, McLeod J . West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis. 2005; 11(11):1774-7. PMC: 3367333. DOI: 10.3201/eid1111.040933. View

Lindsey N, Staples J, Lehman J, Fischer M . Surveillance for human West Nile virus disease - United States, 1999-2008. MMWR Surveill Summ. 2010; 59(2):1-17. View

10.

Hogrefe W, Moore R, Lape-Nixon M, Wagner M, Prince H . Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. J Clin Microbiol. 2004; 42(10):4641-8. PMC: 522294. DOI: 10.1128/JCM.42.10.4641-4648.2004. View

11.

Oceguera 3rd L, Patiris P, Chiles R, Busch M, Tobler L, Hanson C . Flavivirus serology by Western blot analysis. Am J Trop Med Hyg. 2007; 77(1):159-63. View

12.

Nash D, Mostashari F, Fine A, Miller J, OLeary D, Murray K . The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001; 344(24):1807-14. DOI: 10.1056/NEJM200106143442401. View

13.

Zou S, Foster G, Dodd R, Petersen L, Stramer S . West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010; 202(9):1354-61. DOI: 10.1086/656602. View

14.

Busch M, Wright D, Custer B, Tobler L, Stramer S, Kleinman S . West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006; 12(3):395-402. PMC: 3291460. DOI: 10.3201/eid1205.051287. View

15.

Mostashari F, Bunning M, Kitsutani P, Singer D, Nash D, Cooper M . Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001; 358(9278):261-4. DOI: 10.1016/S0140-6736(01)05480-0. View